Doctor profile · Federal record

Dr. David Chesner, D.O.

Rheumatology Physician (CMS: Rheumatology) · Willow Grove, PA

  • NPI 1548247679
  • Accepts Medicare
  • MIPS 76.9 / 100 · 2023
  • 33 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2360 Maryland RD
Willow Grove, PA 19090
(215) 657-6776
fax (215) 366-3339

Credentials & registration

NPPES · NUCC
NPI registered
December 2005 — 21 yrs on file
Profile last updated
November 27, 2023
Year of graduation
1993 — 33 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Pennsylvania #OS008662L

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1548247679. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
133,659
Distinct HCPCS
10
Medicare allowed
$2,083,228
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 42,560 33 $6
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 32,000 22 $5
J3111 Injection, romosozumab-aqqg, 1 mg 13,230 24 $10
J1602 Injection, golimumab, 1 mg, for intravenous use 12,622 30 $13
J0897 Injection, denosumab, 1 mg 12,420 180 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 5,975 32 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,690 38 $33
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg 3,920 17 $47
J9312 Injection, rituximab, 10 mg 2,330 15 $80
99214 Established patient office or other outpatient visit, 30-39 minutes 1,106 469 $135

In context: peer comparison

Among 8 peers in Willow Grove Rheumatology Physician, average services per provider: 5,289. This provider delivers 25× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,700
Transactions
154
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 27 $553.92
Abbvie INC. 25 $499.58
Novartis Pharmaceuticals Corporation 14 $299.07
AstraZeneca Pharmaceuticals Lp 14 $295.19
Janssen Biotech, INC. 9 $278.51
Ucb, INC. 11 $229.30
Ani Pharmaceuticals, INC. 10 $206.91
Boehringer Ingelheim Pharmaceuticals, INC. 7 $194.34
GlaxoSmithKline, LLC. 4 $183.94
E.R. Squibb & Sons, L.L.C. 10 $180.68
Pfizer INC. 9 $161.84
Kyowa Kirin, INC. 4 $86.89
Radius Health, INC. 4 $78.89
Fresenius Kabi USA, LLC 3 $59.83
Sandoz INC. 3 $59.00

By nature of payment

Food and Beverage
$3,601
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,208
Patients
792
Total drug cost
$84,316
Drug Type Claims Patients Total cost
Prednisone Generic 513 117 $6,064
Gabapentin Generic 386 103 $6,636
Hydroxychloroquine Sulfate Generic 344 88 $22,571
Tramadol Hcl Generic 277 62 $1,947
Methylprednisolone Generic 208 84 $2,750
Duloxetine Hcl Generic 206 52 $7,229
Celecoxib Generic 176 54 $6,708
Meloxicam Generic 171 43 $1,306
Methotrexate (Methotrexate Sodium) Brand 169 42 $5,592
Alprazolam Generic 164 28 $1,631

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. David Chesner's medical specialty?
Dr. David Chesner practices Rheumatology Physician in Willow Grove, PA.
Where does Dr. David Chesner practice?
Dr. David Chesner practices at 2360 Maryland RD, Willow Grove, PA 19090. Office phone: 2156576776.
What is Dr. David Chesner's NPI?
Dr. David Chesner's National Provider Identifier (NPI) is 1548247679, issued by NPPES.
Does Dr. David Chesner accept Medicare assignment?
Yes. Dr. David Chesner accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Chesner commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.